Resources

Among healthy middle-aged and older women, Hemoglobin A1c is an independent predictor of type 2 diabetes, but not cardiovascular disease.

Forty-four percent of patients treated with metformin and sitagliptin were able to achieve A1c’s below 6.5%

Patients who stop taking cholesterol-lowering drugs within a year of surviving a stroke had a two-fold increased risk of death, researchers reported.

One reason for this is thought to be the chronic inflammation characterized by macrophage infiltration into adipose tissue that accompanies obesity, because it has been linked to the development of insulin resistance (which in turn often leads to type 2 diabetes).

Thiazolidinediones Receive Black Box For Heart Failure: Careful monitoring of patients advised.

Ruboxistaurin mesylate is used to treat diabetic macular edema and diabetic peripheral neuropathy. The companies said that after looking at the overall results, the trials did not meet the criteria for Phase III studies and therefore they have agreed to terminate the contract.

Compared with people who have not had an AMI, post-AMI patients have a significantly higher risk of developing diabetes or impaired fasting glucose and physicians should consider acute myocardial infarction (AMI) to be a prediabetes risk,authors of a new study say.

U.S. scientists have discovered a third abnormality that might play a role in the development of obesity-induced type 2 diabetes. The development of type 2 diabetes — or at least part of it — may be in your head, researchers said.

The number of uninsured U.S. residents rose by5% and is now by 2.2 million in 2006 to 47 million, up from 44.8 million in 2005, the largest increase in four years, even as poverty fell and household incomes rose, according to data released last Tuesday by the Census Bureau.

Treating gestational diabetes mellitus (GDM) during pregnancy may reduce the child’s risk of becoming obese, according to the results of a new study.